Tracking CTSO? Get live short interest, options flow, and signals on ORTEX.Sign up free →

Cytosorbents Corporation (CTSO) short interest & options flow

NASDAQ

Cytosorbents Corporation filed its Q1 2026 results today — and the stock's 7% single-day drop tells most of the story before you even open the release. Revenue of $8.86 million missed the consensus estimate of $9.36 million. Adjusted EPS of -$0.05 beat the -$0.06 estimate by a penny, but the top-line shortfall dominated the reaction. The miss lands in familiar territory: Germany…

$5.80-0.51% 1d+27.75% 1w+53.03% 1mClose: 10 Nov 2026

Short interest % of float: Low; Live SI on ORTEX →
Cost to borrow: Rising; Live CTB on ORTEX →
Availability: Low; Live availability on ORTEX →

Market cap: $17M
Next earnings: 12 Nov 2026

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of Cytosorbents Corporation (CTSO) share price and short interest (% of free float), six months to November 10, 2026

CTSO news and analysis

RSS

No long-form analysis yet for CTSO. Pulse alerts and the live data picture are available on ORTEX.

Open CTSO on ORTEX →

Want the live picture for CTSO?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CTSO — free to start on ORTEX.

We value your privacy

CTSO news and analysis

Want the live picture for CTSO?